Patrick Baeuerle, Director at TCR2 THERAPEUTICS INC. (TCRR), sold 233,858 shares at $15.16 ($3.6M) on 2019-12-20, disclosed to the SEC on 2019-12-26.
Open-market sale of $3.6M TCRR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.16 | 32,022 | $485K | 13.5% |
| 2 | $15.16 | 32,022 | $485K | 13.5% |
| 3 | $15.44 | 84,907 | $1.3M | 36.5% |
| 4 | $15.44 | 84,907 | $1.3M | 36.5% |
| Total | $15.36 avg | 233,858 | $3.6M | 100% |
| Filing → |
| HARP | SELL | 2019-12-30 | $2.8M | — | Filing → |